Dr. Jessica Rose is a Canadian researcher with a Bachelor’s degree in Applied Mathematics and a Master’s degree in Immunology from Memorial University of Newfoundland. She also holds a Ph.D. in Computational Biology from Bar Ilan University and 2 post-doctoral degrees: one in Molecular Biology from the Hebrew University of Jerusalem and one in Biochemistry from the Technion Institute of Technology. She was also accepted for a 2-month program as a senior researcher at the Weizmann Institute prior to completion of her latest post-doctoral degree at the Technion. These modalities have given her a solid base in which she uses to deep dive into VAERS (Vaccine Adverse Events Reporting System) reports and provide data analysis surrounding the adverse events profile of the current CV19 injectables.
Dr. Rose also co-authored a paper with Dr. Peter McCullough — in which they found a 19x risk of myocarditis in males aged 12-15 post injections — that was conveniently scrubbed from publication five days before she was set to present the findings to the FDA approval committee for 5- to 11-year-olds.
